CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-002084
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Glucosylceramidase 
Protein Synonyms/Alias
 Acid beta-glucosidase; Alglucerase; Beta-glucocerebrosidase; D-glucosyl-N-acylsphingosine glucohydrolase; Imiglucerase 
Gene Name
 GBA 
Gene Synonyms/Alias
 GC; GLUC 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
118EQKFQKVKGFGGAMTubiquitination[1]
225WTSPTWLKTNGAVNGubiquitination[1]
332LLLPHWAKVVLTDPEubiquitination[2]
447PIIVDITKDTFYKQPubiquitination[2]
Reference
 [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [2] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983
Functional Description
  
Sequence Annotation
 ACT_SITE 274 274 Proton donor.
 ACT_SITE 379 379 Nucleophile.
 CARBOHYD 58 58 N-linked (GlcNAc...).
 CARBOHYD 98 98 N-linked (GlcNAc...).
 CARBOHYD 185 185 N-linked (GlcNAc...).
 CARBOHYD 309 309 N-linked (GlcNAc...).
 CARBOHYD 501 501 N-linked (GlcNAc...) (Potential).
 DISULFID 43 55
 DISULFID 57 62  
Keyword
 3D-structure; Alternative initiation; Alternative splicing; Complete proteome; Direct protein sequencing; Disease mutation; Disulfide bond; Gaucher disease; Glycoprotein; Glycosidase; Hydrolase; Ichthyosis; Lipid metabolism; Lysosome; Membrane; Neurodegeneration; Parkinson disease; Parkinsonism; Pharmaceutical; Polymorphism; Reference proteome; Signal; Sphingolipid metabolism. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 536 AA 
Protein Sequence
MEFSSPSREE CPKPLSRVSI MAGSLTGLLL LQAVSWASGA RPCIPKSFGY SSVVCVCNAT 60
YCDSFDPPTF PALGTFSRYE STRSGRRMEL SMGPIQANHT GTGLLLTLQP EQKFQKVKGF 120
GGAMTDAAAL NILALSPPAQ NLLLKSYFSE EGIGYNIIRV PMASCDFSIR TYTYADTPDD 180
FQLHNFSLPE EDTKLKIPLI HRALQLAQRP VSLLASPWTS PTWLKTNGAV NGKGSLKGQP 240
GDIYHQTWAR YFVKFLDAYA EHKLQFWAVT AENEPSAGLL SGYPFQCLGF TPEHQRDFIA 300
RDLGPTLANS THHNVRLLML DDQRLLLPHW AKVVLTDPEA AKYVHGIAVH WYLDFLAPAK 360
ATLGETHRLF PNTMLFASEA CVGSKFWEQS VRLGSWDRGM QYSHSIITNL LYHVVGWTDW 420
NLALNPEGGP NWVRNFVDSP IIVDITKDTF YKQPMFYHLG HFSKFIPEGS QRVGLVASQK 480
NDLDAVALMH PDGSAVVVVL NRSSKDVPLT IKDPAVGFLE TISPGYSIHT YLWRRQ 536 
Gene Ontology
 GO:0043202; C:lysosomal lumen; ISS:BHF-UCL.
 GO:0005765; C:lysosomal membrane; ISS:BHF-UCL.
 GO:0004348; F:glucosylceramidase activity; IDA:BHF-UCL.
 GO:0005102; F:receptor binding; ISS:BHF-UCL.
 GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
 GO:0008219; P:cell death; IEA:UniProtKB-KW.
 GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL.
 GO:0046513; P:ceramide biosynthetic process; IMP:BHF-UCL.
 GO:0006680; P:glucosylceramide catabolic process; IMP:BHF-UCL.
 GO:0050728; P:negative regulation of inflammatory response; IC:BHF-UCL.
 GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL.
 GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL.
 GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL.
 GO:0046512; P:sphingosine biosynthetic process; IMP:BHF-UCL.
 GO:0023021; P:termination of signal transduction; IMP:BHF-UCL. 
Interpro
 IPR013780; Glyco_hydro_13_b.
 IPR001139; Glyco_hydro_30.
 IPR013781; Glyco_hydro_catalytic_dom.
 IPR017853; Glycoside_hydrolase_SF. 
Pfam
 PF02055; Glyco_hydro_30 
SMART
  
PROSITE
  
PRINTS
 PR00843; GLHYDRLASE30.